Treatment of Squamous Cell Carcinoma of the Anus, Unresolved Areas and Future Perspectives for Research: Perspectives of Research Needs in Anal Cancer

Marianne Grønlie Guren, David Sebag-Montefiore, Pierfrancesco Franco, Anders Johnsson, Eva Segelov, Eric Deutsch, Sheela Rao, Karen Lise Garm Spindler, Dirk Arnold

Research output: Contribution to journalArticleResearchpeer-review


Anal cancer is a relatively rare, mostly HPV-related cancer. The curative treatment consists of concurrent chemoradiation delivered with modern radiotherapy techniques. The prognosis for most patients with early localized disease is very favourable; however patients with locally advanced disease and/or HPV negative tumours are at higher risk of locoregional and distant treatment failure. Tailored approaches are presently being investigated to determine the most suitable regimen in terms of radiotherapy dose prescription, target volume selection, normal tissue avoidance, and combination therapy. Metastatic anal cancer is treated with chemotherapy aiming at prolonged survival. The role of immune therapy in the clinical setting is being investigated. There is little knowledge on the biology of anal cancer, and an urgent need for more clinical and translational research dedicated to this disease. In this article, the evidence-base for the current treatment is briefly reviewed, and perspectives on future research needs are high-lighted.

Original languageEnglish
Number of pages9
JournalClinical Colorectal Cancer
Publication statusAccepted/In press - 2021


  • Chemotherapy
  • Human papilloma virus
  • Immune checkpoint inhibition
  • Radiotherapy

Cite this